| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/19/2011 | US20110118440 Gamma amino acid building blocks |
| 05/19/2011 | US20110118186 Synthetic peptide amides and dimeric forms thereof |
| 05/19/2011 | US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 05/19/2011 | US20110117009 Drug conjugates with polyglycerols |
| 05/19/2011 | CA2779417A1 Therapeutic agent for gastrointestinal disease |
| 05/18/2011 | EP2322649A1 Method for rapid detection and identification of bioagents |
| 05/18/2011 | EP2322537A1 Tubulin inhibitors |
| 05/18/2011 | EP2322536A2 Aminothiazole derivatives and their uses as antibacterial agents |
| 05/18/2011 | EP2320751A2 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof |
| 05/18/2011 | EP2036920B1 Cycloalkylcarbonylamino acid ester derivative and process for producing the same |
| 05/18/2011 | EP1989324B1 Pcr hot start by magnesium sequestration |
| 05/18/2011 | EP1575867B1 Peptide nanostructures, methods for their preparation and use |
| 05/18/2011 | EP1467969B1 Dna minor groove binding compounds |
| 05/18/2011 | CN1982329B Biologically active peptide comprising tyrosyl-seryl-valine (YSV) and use thereof |
| 05/18/2011 | CN1805932B Process and intermediates for the preparation of hepatitis C virus protease inhibitor |
| 05/18/2011 | CN102066402A Peptide derivative and composition for promoting tear secretion comprising the same |
| 05/18/2011 | CN102066325A Heteroaromatic monoamides as orexinin receptor antagonists |
| 05/18/2011 | CN102060908A Novel synthetic antithrombotic polypeptide, and preparation method and application thereof |
| 05/18/2011 | CN102060723A Preparation method of cationic liposome nanoparticles of amino acid |
| 05/17/2011 | USRE42375 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 05/17/2011 | US7943763 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 05/17/2011 | US7943728 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 05/17/2011 | US7943578 tripeptide Leu-Val-Tyr as hypotensive agent for reducing blood pressure; edible; being of food origin; from sesame meal |
| 05/17/2011 | US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2197672C Tetrahydrofuran antifungals |
| 05/12/2011 | WO2011055880A1 Novel peptide promoting the expression of bdnf, and pharmaceutical composition including same for preventing and treating alzheimer's and parkinson's diseases |
| 05/12/2011 | WO2011055247A1 A synthetic cyclic dipeptide and a process thereof |
| 05/12/2011 | US20110110875 Angiogenic peptide |
| 05/12/2011 | CA2778922A1 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates |
| 05/11/2011 | EP2319894A1 Novel lipid dipeptide and gel |
| 05/11/2011 | EP2319859A2 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2318419A1 Boronate ester compounds and pharmaceutical compositions thereof |
| 05/11/2011 | EP2318395A2 Inhibitors of iap |
| 05/11/2011 | EP1163262B1 Phenylalanine derivatives |
| 05/11/2011 | CN102050867A Tetrapeptide analog, preparation method and application thereof |
| 05/11/2011 | CN101061134B Novel topical application agents against mimic and age-related wrinkles |
| 05/10/2011 | US7939667 Hepatitis C inhibitor compounds |
| 05/10/2011 | US7939628 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 05/10/2011 | US7939624 Peptide able to break the m-p53/p63, m-p53/p73 and m-p53/respective isoform proteins complex formed in the tumor cells and uses thereof in the pharmacological field |
| 05/10/2011 | US7939302 Process for producing dipeptides |
| 05/10/2011 | CA2486675C Gelling agents |
| 05/10/2011 | CA2363712C Long lasting insulinotropic peptides |
| 05/05/2011 | WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | WO2011051692A1 Therapeutic peptides |
| 05/05/2011 | WO2011050471A1 Yellow pea seed protein-derived peptides |
| 05/05/2011 | US20110105415 Gene regulator |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104071 Methods and systems for spatially identifying abnormal cells |
| 05/05/2011 | US20110104063 Flexibly labeling peptides |
| 05/05/2011 | CA2779161A1 Yellow pea seed protein-derived peptides |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | CA2777749A1 Therapeutic peptides |
| 05/04/2011 | EP2317317A1 Prion protein ligands and methods of use |
| 05/04/2011 | EP2316849A2 Polypeptides comprising RER, derivatives and uses thereof |
| 05/04/2011 | EP2316846A2 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316844A2 Peptide complex |
| 05/04/2011 | EP2316830A2 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors |
| 05/04/2011 | EP2316470A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |
| 05/04/2011 | EP2316035A2 Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
| 05/04/2011 | EP1733231B1 Peptides and peptidomimetics binding to cd23 |
| 05/04/2011 | CN102046648A Hepatitis c virus inhibitors |
| 05/04/2011 | CN102046622A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 05/04/2011 | CN102040651A Preparation method of phthaloyl-L-alanyl-L-glutamine |
| 05/04/2011 | CN102038932A Metal-binding compounds and uses therefor |
| 05/04/2011 | CN101215544B Inflammation-inhibiting compounds |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | US7935785 Selective substrates for matrix metalloproteinases |
| 05/03/2011 | US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/28/2011 | WO2011048390A2 Gadd45beta targeting agents |
| 04/28/2011 | WO2011047926A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents |
| 04/28/2011 | WO2011047812A1 Diselenide-resins for oxidative protein folding |
| 04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| 04/28/2011 | US20110098235 Antineoplastic peptides |
| 04/28/2011 | US20110098218 Modulators of stat3 signalling |
| 04/28/2011 | US20110097758 Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay |
| 04/28/2011 | US20110097735 Fluorescent pyrene compounds |
| 04/28/2011 | US20110097264 Radiolabeling method using multivalent glycoligands as hepatic receptor imaging agent |
| 04/28/2011 | CA2778503A1 Macrocyclic inhibitors of serine protease enzymes |
| 04/28/2011 | CA2778236A1 Gadd45beta targeting agents |
| 04/27/2011 | EP2314646A1 Diselenide-resins for oxidative protein folding |
| 04/27/2011 | EP2314598A1 Inhibitors of Hepatitis C virus NS3 serine protease |
| 04/27/2011 | EP1959938B1 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 04/27/2011 | EP1456394B2 Methods of using improved polymerases |
| 04/27/2011 | CN102037005A New optically pure compounds for improved therapeutic efficiency |
| 04/27/2011 | CN102030818A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030817A Peptide inhibiting angiontensin converting enzyme |
| 04/27/2011 | CN102030811A Phytolaccagenin derivative and preparation method and application thereof |
| 04/27/2011 | CN101245094B Liquid phase synthesizing method of peptide aldehyde |
| 04/26/2011 | US7932382 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | CA2522577C Hepatitis c inhibitor compounds |
| 04/26/2011 | CA2509765C Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them |
| 04/26/2011 | CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 04/26/2011 | CA2398497C Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 04/26/2011 | CA2376064C Factor viia inhibitors |
| 04/21/2011 | WO2011047190A1 Gamma amino acid building blocks |